These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 25595637)

  • 21. Ebola: a review for emergency providers.
    Torres M; Hansen KN; Jerrard D
    Emerg Med Clin North Am; 2015 May; 33(2):e1-18. PubMed ID: 26065304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons learned from Ebola Vaccine R&D during a public health emergency.
    Kieny MP
    Hum Vaccin Immunother; 2018; 14(9):2114-2115. PubMed ID: 29452047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early trials of Ebola vaccine show immune response.
    Mayor S
    BMJ; 2015 Apr; 350():h1844. PubMed ID: 25855620
    [No Abstract]   [Full Text] [Related]  

  • 24. Ebola Virus: Pathogenesis and Countermeasure Development.
    Furuyama W; Marzi A
    Annu Rev Virol; 2019 Sep; 6(1):435-458. PubMed ID: 31567063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccines against Ebola virus.
    Venkatraman N; Silman D; Folegatti PM; Hill AVS
    Vaccine; 2018 Aug; 36(36):5454-5459. PubMed ID: 28780120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Closer than ever to an Ebola virus vaccine.
    Banadyga L; Marzi A
    Expert Rev Vaccines; 2017 May; 16(5):401-402. PubMed ID: 28322076
    [No Abstract]   [Full Text] [Related]  

  • 27. Ebola haemorrhagic fever virus: pathogenesis, immune responses, potential prevention.
    Marcinkiewicz J; Bryniarski K; Nazimek K
    Folia Med Cracov; 2014; 54(3):39-48. PubMed ID: 25694094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ebola virus vaccines: an overview of current approaches.
    Marzi A; Feldmann H
    Expert Rev Vaccines; 2014 Apr; 13(4):521-31. PubMed ID: 24575870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guns N' viruses.
    Häfner S
    Microbes Infect; 2019; 21(3-4):125-128. PubMed ID: 30684684
    [No Abstract]   [Full Text] [Related]  

  • 30. [Potential vaccine candidates against Ebola and the first vaccine against chikungunya virus infection].
    Nau JY
    Rev Med Suisse; 2014 Aug; 10(439):1570-1. PubMed ID: 25272676
    [No Abstract]   [Full Text] [Related]  

  • 31. [Overview of the Ebola vaccines in pre-clinical and clinical development].
    Buchy P
    Bull Soc Pathol Exot; 2016 Oct; 109(4):256-261. PubMed ID: 27646961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
    Henao-Restrepo AM; Longini IM; Egger M; Dean NE; Edmunds WJ; Camacho A; Carroll MW; Doumbia M; Draguez B; Duraffour S; Enwere G; Grais R; Gunther S; Hossmann S; Kondé MK; Kone S; Kuisma E; Levine MM; Mandal S; Norheim G; Riveros X; Soumah A; Trelle S; Vicari AS; Watson CH; Kéïta S; Kieny MP; Røttingen JA
    Lancet; 2015 Aug; 386(9996):857-66. PubMed ID: 26248676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Advances in the Effort against Ebola.
    Saphire EO
    Cell Host Microbe; 2015 May; 17(5):545-7. PubMed ID: 25974296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals.
    Wong G; Richardson JS; Cutts T; Qiu X; Kobinger GP
    Antiviral Res; 2015 Apr; 116():17-9. PubMed ID: 25596432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant vesicular stomatitis virus expressing Ebola virus glycoprotein (rVSV-EBOV), a new Ebola vaccine.
    Kasereka MC; Mumtaz Z; Hawkes MT
    Drugs Today (Barc); 2021 Jan; 57(1):27-45. PubMed ID: 33594388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions.
    Mbala-Kingebeni P; Villabona-Arenas CJ; Vidal N; Likofata J; Nsio-Mbeta J; Makiala-Mandanda S; Mukadi D; Mukadi P; Kumakamba C; Djokolo B; Ayouba A; Delaporte E; Peeters M; Muyembe Tamfum JJ; Ahuka-Mundeke S
    Clin Infect Dis; 2019 Jan; 68(2):330-333. PubMed ID: 29961823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approaches to demonstration of Ebola virus vaccine efficacy.
    Krause PR; Cavaleri M; Coleman G; Gruber MF
    Lancet Infect Dis; 2015 Jun; 15(6):627-9. PubMed ID: 26008825
    [No Abstract]   [Full Text] [Related]  

  • 38. Ebola vaccines in clinical trial: The promising candidates.
    Wang Y; Li J; Hu Y; Liang Q; Wei M; Zhu F
    Hum Vaccin Immunother; 2017 Jan; 13(1):153-168. PubMed ID: 27764560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ebola Virus Disease: Epidemiology, Clinical Features, Management, and Prevention.
    Nicastri E; Kobinger G; Vairo F; Montaldo C; Mboera LEG; Ansunama R; Zumla A; Ippolito G
    Infect Dis Clin North Am; 2019 Dec; 33(4):953-976. PubMed ID: 31668200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ebola virus: unravelling pathogenesis to combat a deadly disease.
    Hoenen T; Groseth A; Falzarano D; Feldmann H
    Trends Mol Med; 2006 May; 12(5):206-15. PubMed ID: 16616875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.